Cyclic dipeptides, also know as diketopiperazines (DKP), the simplest cyclic forms of peptides widespread in nature, are unsurpassed in their structural and bio-functional diversity. DKPs, especially those containing proline, due to their unique features such as, inter alia, extra-rigid conformation, high resistance to enzyme degradation, increased cell permeability, and expandable ability to bind a diverse of targets with better affinity, have emerged in the last years as biologically pre-validated platforms for the drug discovery. Recent advances have revealed their enormous potential in the development of next-generation theranostics, smart delivery systems, and biomaterials. Here, we present an updated review on the biological and structural profile of these appealing biomolecules, with a particular emphasis on those with anticancer properties, since cancers are the main cause of death all over the world. Additionally, we provide a consideration on supramolecular structuring and synthons, based on the proline-based DKP privileged scaffold, for inspiration in the design of compound libraries in search of ideal ligands, innovative self-assembled nanomaterials, and bio-functional architectures.
We designed a library of 24 cyclic peptides containing
arginine
(R) and tryptophan (W) residues in a sequential manner [R
n
W
n
] (n = 2–7) to study the impact of the hydrophilic/hydrophobic
ratio, charge, and ring size on the antibacterial activity against
Gram-positive and Gram-negative strains. Among peptides, 5a and 6a demonstrated the highest antimicrobial activity.
In combination with 11 commercially available antibiotics, 5a and 6a showed remarkable synergism against a large
panel of resistant pathogens. Hemolysis (HC50 = 340 μg/mL)
and cell viability against mammalian cells demonstrated the selective
lethal action of 5a against bacteria over mammalian cells.
Calcein dye leakage and scanning electron microscopy studies revealed
the membranolytic effect of 5a. Moreover, the stability
in human plasma (t
1/2 = 3 h) and the negligible
ability of pathogens to develop resistance further reflect the potential
of 5a for further development as a peptide-based antibiotic.
Aim
Small‐conductance Ca2+‐activated potassium (SK) channels are activated exclusively by increases in intracellular Ca2+ that binds to calmodulin constitutively associated with the channel. Wild‐type SK2 channels are activated by Ca2+ with an EC50 value of ~0.3 μmol/L. Here, we investigate hydrophobic interactions between the HA helix and the S4‐S5 linker as a major determinant of channel apparent Ca2+ sensitivity.
Methods
Site‐directed mutagenesis, electrophysiological recordings and molecular dynamic (MD) simulations were utilized.
Results
Mutations that decrease hydrophobicity at the HA‐S4‐S5 interface lead to Ca2+ hyposensitivity of SK2 channels. Mutations that increase hydrophobicity result in hypersensitivity to Ca2+. The Ca2+ hypersensitivity of the V407F mutant relies on the interaction of the cognate phenylalanine with the S4‐S5 linker in the SK2 channel. Replacing the S4‐S5 linker of the SK2 channel with the S4‐S5 linker of the SK4 channel results in loss of the hypersensitivity caused by V407F. This difference between the S4‐S5 linkers of SK2 and SK4 channels can be partially attributed to I295 equivalent to a valine in the SK4 channel. A N293A mutation in the S4‐S5 linker also increases hydrophobicity at the HA‐S4‐S5 interface and elevates the channel apparent Ca2+ sensitivity. The double N293A/V407F mutations generate a highly Ca2+ sensitive channel, with an EC50 of 0.02 μmol/L. The MD simulations of this double‐mutant channel revealed a larger channel cytoplasmic gate.
Conclusion
The electrophysiological data and MD simulations collectively suggest a crucial role of the interactions between the HA helix and S4‐S5 linker in the apparent Ca2+ sensitivity of SK2 channels.
RNA
interference (RNAi) is a powerful tool capable of targeting virtually
any protein without
time-consuming and expensive drug development studies. However, due
to obstacles facing efficient and safe delivery, RNAi-based therapeutic
approach remains a challenge. Herein, we have designed and synthesized
a number of disulfide-constraining cyclic and hybrid peptides using
tryptophan and arginine residues. Our hypothesis was that peptide
structures would undergo reduction by intracellular glutathione (more
abundant in cancer cells) and unpack the small interfering RNA (siRNA)
from the peptide/siRNA complexes. A subset of newly developed peptides
(specifically, C4 and H4) exhibited effective
cellular internalization of siRNA (∼70% of the cell population;
monitored by flow cytometry and confocal microscopy), the capability
of protecting siRNA against early degradation by nucleases (monitored
by gel electrophoresis), minimal cytotoxicity in selected cell lines
(studied by cell viability and LC50 calculations), and
efficient protein silencing by 70–75% reduction in the expression
of targeting signal transducer and activator of transcription 3 (STAT3)
in human triple-negative breast cancer (TNBC) MDA-MB-231 cells, analyzed
using the Western blot technique. Our results indicate the birth of
a promising new family of siRNA delivery systems that are capable
of safe and efficient delivery, even in the presence of nucleases.
The COVID-19 pandemic is still posing challenging health and economic problems. Effective broad-spectrum antiviral therapy is urgently needed for the control of early SARS-CoV-2 infection to limit its spread and mutations. In this randomized placebo-controlled clinical study, we tested the effects of intranasal and oropharyngeal delivery of a compound of povidone-iodine 0.5% and glycyrrhizic acid 2.5 mg/ml on the laboratory (PCR) and clinical recovery from SARS-CoV-2 patients and their household contacts. 353 patients suspected of having COVID-19 infection were screened by chest CT and nasopharyngeal swab tests (PCR). 200 patients were randomly allocated to two equal groups: treatment and placebo groups. Treatment accelerated the recovery of PCR on days 4, 7, and 10, as evidenced by PCR-positive patients (70, vs. 99%, 20 vs. 65%, 1 vs. 10%) in both the treated and placebo groups, respectively. Treatment enhanced the early recovery of symptoms [day 7.6 ± 2 (CI 7:8.3) vs. 8.9 ± 2 (CI 8.3:9.6)]. Treatment promoted early recovery of anosmia and ageusia [5.6 ± 1 (CI, 4.8:6.4) vs. 11 ± 3 days, (CI, 10.8:12)] in both the treated and control groups (P < 0.0001). There was a notable reduction in transmission of the virus among the household close contacts in the treatment group (4%) vs. 76% in the placebo group. Combined PVI-GA nasal and oropharyngeal spray accelerates both laboratory and clinical recovery of SARS-CoV-2 infected patients in the early phases of the disease and reduces the household spread of the virus; thus, it may play an important role in controlling coronavirus outbreaks.Clinical Trial Registrationhttps://pactr.samrc.ac.za, PACTR202101875903773.
We have previously reported cyclic cell-penetrating peptides [WR]5 and [WR]4 as molecular transporters. To optimize further the utility of our developed peptides for targeted therapy in cancer cells using the redox condition, we designed a new generation of peptides and evaluated their cytotoxicity as well as uptake behavior against different cancer cell lines. Thus, cyclic [C(WR)xC] and linear counterparts (C(WR)xC), where x = 4–5, were synthesized using Fmoc/tBu solid-phase peptide synthesis, purified, and characterized. The compounds did not show any significant cytotoxicity (at 25 µM) against ovarian (SK-OV-3), leukemia (CCRF-CEM), gastric adenocarcinoma (CRL-1739), breast carcinoma (MDA-MB-231), and normal kidney (LLCPK) cells after 24 and 72 h incubation. Both cyclic [C(WR)5C] and linear (C(WR)5C) demonstrated comparable molecular transporter properties versus [WR]5 in the delivery of a phosphopeptide (F′-GpYEEI) in CCRF-CEM cells. The uptake of F′-GpYEEI in the presence of 1,4-dithiothreitol (DTT) as the reducing agent was significantly improved in case of l(C(WR)5C), while it was not changed by [C(WR)5C]. Fluorescence microscopy also demonstrated a significant uptake of F′-GpYEEI in the presence of l(C(WR)5C). Cyclic [C(WR)5C] improved the uptake of the fluorescent-labeled anti-HIV drugs F′-d4T, F′-3TC, and F′-FTC by 3.0–4.9-fold. These data indicate that both [C(WR)5C] and linear (C(WR)5C) peptides can act as molecular transporters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.